[Luzindol accelerates the aging of estrous function of female rats]. 2016

O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
Petrozavodsk State University, Petrozavodsk, 185000, Russian Federation; zhykovaoxana@yandex.ru.

In this paper, we investigated the dynamics of aging of the estrous function of female rats kept in the conditions of standard vivarium lighting and receiving luzindol - the blocker of melatonin receptors. Every three months, daily, for two weeks, vaginal smears were taken from the animals and cytological examination of the vaginal contents was conducted. Despite different mechanisms of the development of melatonin system failure (a decreased production of melatonin and a blockade of melatonin receptors), the effects of the influence on the ovulatory function are similar. In case of the blockade of melatonin receptors, the appearance of premature signs of aging of the reproductive function in rats was observed. It was manifested by an increased duration of ovulatory cycle; a decrease in the number of regular cycles; the emergence of irregular cycles; a decrease in the number of short estrous cycles and an increase of long cycles; the early development of persistent estrus.

UI MeSH Term Description Entries
D004971 Estrus The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
D005260 Female Females
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014363 Tryptamines Decarboxylated monoamine derivatives of TRYPTOPHAN. Indolylethylamines,Triptan,Triptans
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D044122 Receptor, Melatonin, MT1 A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY. Melatonin MT1 Receptor,MT1 Receptor,Mel(1a)-Melatonin Receptor,MT1 Receptor, Melatonin,Receptor, MT1,Receptor, Melatonin MT1
D044123 Receptor, Melatonin, MT2 A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA. Melatonin MT2 Receptor,MT2 Receptor,Mel 1b Receptor,Melatonin 1b Receptor,MT2 Receptor, Melatonin,Receptor, MT2,Receptor, Melatonin 1b,Receptor, Melatonin MT2
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
April 2007, Experimental animals,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
December 1986, Biology of reproduction,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
January 1999, Advances in experimental medicine and biology,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
September 2012, Journal of applied physiology (Bethesda, Md. : 1985),
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
September 1987, Biology of reproduction,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
May 1985, Endocrinology,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
January 1999, Physiology & behavior,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
June 2020, Learning & memory (Cold Spring Harbor, N.Y.),
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
December 1989, Hormones and behavior,
O V Zhukova, and E S Obukhova, and E A Khizhkin, and V A Ilukha, and I A Vinogradova
September 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!